About Us

10+ years championing Real-World Evidence for better healthcare decision making

our story

Purpose

GetReal is an independent, multi-stakeholder European forum dedicated to advancing the adoption and implementation of Real-World Evidence (RWE) in regulatory, health technology assessment, and clinical decision-making.

We bring together diverse voices to shape the future of healthcare, ensuring that RWE plays a central role in improving patient outcomes and healthcare decision processes across Europe.

Our Story

The GetReal Institute emerged from two acclaimed programmes propelled by the Innovative Medicine Initiatives (IMI).

Both the GetReal Project and the GetReal Initiative, shaped our reputation as a collaborative multi-stakeholder body with a mission to facilitate the adoption and implementation of real-world evidence in health-care decision-making in Europe.

Timeline

2013
GetReal Project

The GetReal Project (2013-2017) was established to demonstrate how robust new methods of real-world data (RWD) collection and synthesis could be adopted earlier in pharmaceutical research and development and the healthcare decision-making process..

2013
2018
GetReal Initiative

The GetReal Initiative (2018-2021) continued to drive the adoption of tools, methodologies and best practice to increase the quality of real-world evidence (RWE) generation in medicines development and regulatory/health technology assessment (HTA) processes across Europe.

2018
2021
GetReal Institute

The GetReal Institute is established as an independent multi-stakeholder forum for collaboration in the adoption and implementation of RWE.

2021

The GetReal Institute provides a unique platform to facilitate identifying and tackling the need to improve the safe and effective use of medicines by patients in collaboration with the relevant stakeholders.

Helga Gardarsdottir, Associate Professor at the Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University

oversight

Governance

Our governance is steered by an elected six-person Board of Directors, which will soon expand to a robust nine-person team, representing diverse sectors, including industry, academia, patients, regulatory and health technology assessment, fortifying our multi-stakeholder approach.

methodology

Our Approach

With a mission to facilitate the adoption and implementation of real-world evidence in regulatory, HTA and clinical decision-making in Europe.

At the core of our identity is the spirit of collaboration and knowledge sharing. Through symposia, webinars, conferences, and workshops, we created platforms for the exchange of ideas and the cross-pollination of expertise.

Convening

Gathering multiple stakeholders across the evidence generation community to share varied experiences, expertise and perspectives.

Collaboration

Fostering spaces for members to engage in fruitful discussions, exchange insights, and collectively explore innovative approaches, best practices, and emerging trends and methodologies.

Curation

Identifying and sharing resources  and experiences relevant to different stakeholders.

Contribution

Creating resources, sharing best practice and guidance that increase clarity and identify appropriate applications of RWE.

Working Groups

As a member-led and agile organisation, the GetReal Institute taps into the strengths, expertise, and interests of our members through four strategic working groups. These groups are focused on advancing the adoption and use of Real-World Evidence (RWE) in key areas of healthcare. Each working group collaborates towards specific, measurable goals to drive progress in the RWE landscape:

Working Group 1

Collaboration & Engagement

Driving stakeholders to make impactful change

Objective: Establish a sustainable, neutral forum to bring together key stakeholders, fostering partnerships and driving the adoption of evidence-based decision-making in policy.

Strategy:

  1. Create a hub for RWD/RWE thought leadership, connecting initiatives and promoting collaborative projects.
  2. Facilitate multi-stakeholder engagement to amplify the impact of RWE.
  3. Provide a platform for common understanding and prioritization of critical opportunities and challenges in RWE generation and use.
  4. Build a diverse, member-led community to promote inclusive engagement.
  5. Drive innovative partnerships and collaborative projects to advance RWE in decision-making.
Working Group 2

Data & Methods

Advancing the use of RWD and RWE methodologies

Objective: Serve as an incubator for developing strategies and tools that address scientific and operational uncertainties in RWE methodologies.

Strategy:

  1. Advance RWD and RWE methodologies to build confidence in their application.
  2. Develop a scientific agenda to meet the needs of regulatory and HTA bodies in applying RWE.
  3. Contribute to cutting-edge research that shapes policy and guidance, enhancing the use of RWE.
Working Group 3

Knowledge Dissemination

Propagating knowledge to shape the future

Objective: Curate and share a valuable repository of RWE resources, success stories, and experiences to shape the future of RWE adoption.

Strategy:

  1. Collect and disseminate a centralised repository of resources, success stories, and scientific publications.
  2. Organise webinars, workshops, and events to share knowledge and drive RWE adoption across disciplines.
  3. Establish thought leadership in advancing RWE understanding, application, and adoption.
  4. Empower decision-makers with clear, evidence-backed insights on RWE healthcare applications.
Working Group 4

Education & Training

Cultivating a community of RWE experts

Objective: Position the GetReal Academy as a premier hub for RWE education, cultivating a community of experts who drive informed, evidence-based decision-making in healthcare.

Strategy:

  1. Offer specialised online courses, workshops, and mentorship programs led by RWE experts.
  2. Cultivate a diverse community of RWE professionals, healthcare providers, researchers, and policy-makers.
  3. Equip stakeholders with the skills and knowledge to proficiently apply RWE methodologies in regulatory, HTA, and clinical settings.
Scroll to Top